Study Conduct Sub-Domain::TargetAnatomicSite

: Public Class

Created:	8/1/2012 9:46:14 AM
Modified:	12/8/2017 2:39:07 PM

Project:
Author:	BRIDG SCC
Version:	1.0
Phase:	1.0
Status:
Complexity:	Easy
Difficulty:
Priority:
Multiplicity:
Advanced:
UUID:	{5EA1825F-52A2-44c4-A30B-CF409CB9B526}
Appears In:	UML-Based Comprehensive BRIDG Model Diagram, View SC: Study Conduct, View IM: Imaging, Observations and Results, DICOM SR TID 1500 BRIDG Class Diagram, Oncology & Imaging View, SDTM 3.1.3 View, Participant Registration, SEER View

DEFINITION: An anatomic location that is the focus of an observation result. EXAMPLE(S): brainstem, spinal cord for a lesion arm for skin rash OTHER NAME(S): NOTE(S):

Attributes
Associations To
Tagged Values

Attribute

Public CD
code

Details:

Alias:
Initial:
Stereotype:
Ordered:
Range:	Range:1. to 1
Transient:	False
Derived:	False
IsID:	False

Map:AE=AdverseEvent.bodyLocation
Map:AIM v4 rv48=ImagingPhysicalEntity.typeCode
Map:C3PRv2.9=ICD9DiseaseSite
Map:C3PRv2.9=ICD9DiseaseSite.name
Map:C3PRv2.9=ICD9DiseaseSite.code
Map:C3PRv2.9=DiseaseHistory.otherPrimaryDiseaseSiteCode
Map:caAERSv2.2=AnatomicSite.name > DiseaseHistory
Map:caAERSv2.2=MetastaticDiseaseSite.otherSite > StudyParticipantDiseaseHistory
Map:caAERSv2.2=AnatomicSite.name > StudyParticipationDiseaseHistory
Map:caAERSv2.2=DiseaseHistory.otherPrimaryDiseaseSite
Map:caAERSv2.2=MetastaticDiseaseSite
Map:caAERSv2.2=StudyParticipantDiseaseHistory.otherPrimaryDiseaseSite
Map:caAERSv2.2=MetastaticDiseaseSite.otherSite > DiseaseHistory
Map:caAERSv2.2=MetastaticDiseaseSite > DiseaseHistory
Map:CTOM=Diagnosis.primaryAnatomicSiteLateralityCode
Map:CTOM=LesionDescription.anatomicSiteCode
Map:CTOM=LesionDescription.anatomicSiteCodeSystem
Map:CTOM=Diagnosis.primaryAnatomicSiteCode
Map:CTOM=Diagnosis.primaryAnatomicSiteCodeSystem
Map:CTRv1.0=PerformedObservationResult.targetAnatomicSiteCode
Map:DICOM=TID 1501 MeasurementGroup > Measurement Group > Finding Site
Map:DICOM=TID 1419 ROIMeasurements > $Measurement parameter > Finding Site
Map:DICOM=Measurement Group > Finding Site > Measurement Group > Finding Site
Map:DICOM=TID 300 Measurement > $Measurement parameter > Finding Site
Map:HCTv1.0=CDE 3124482:Anatomic Sites.Specify other site:
Map:HCTv1.0=CDE 2978277:Anatomic Sites.Specify site(s) of relapse/progression:
Map:HCTv1.0=CDE 2970615:Involvement and Extent of Disease.Specify other sites:
Map:HCTv1.0=CDE 2961431:Involvement and Extent of Disease.Specify metastasis anatomic site:
Map:HCTv1.0=CDE 3057312:Anatomic Sites.On what eye was the examination performed?
Map:HCTv1.0=CDE 3031379:Anatomic Sites.Specify the known site(s) of disease progression / recurrence:
Map:HCTv1.0=CDE 3133376:Involvement and Extent of Disease.What is the disease involvment site name?
Map:HCTv1.0=CDE 3020048:Disease, Disorder or Finding.Specify location of the central nervous system abnormalities:
Map:HCTv1.0=CDE 3005935:Involvement and Extent of Disease.Specify amyloidosis other system response:
Map:HCTv1.0=CDE 2760980:Disease, Disorder or Finding.Specify site(s) of active leukemia:
Map:HCTv1.0=CDE 2970440:Lab Results.What tissues were analyzed?
Map:HCTv1.0=CDE 2987033:Anatomic Sites.What was the site of the extragonadal germ cell metastases?
Map:HCTv1.0=CDE 2986153:Anatomic Sites.Specify site of extra-gonadal germ cell tumor:
Map:HCTv1.0=CDE 2739572:Disease, Disorder or Finding.Specify other extramedullary diease site
Map:HCTv1.0=CDE 65154 /:Involvement and Extent of Disease.Site of Involvement
Map:HCTv1.0=CDE 2967296:Anatomic Sites.Specify other site:
Map:HCTv1.0=CDE 2739560:Disease, Disorder or Finding.Specify extramedullary diease site type:
Map:HCTv1.0=CDE 2971708:Disease Response.Which site?
Map:HCTv1.0=CDE 2986193:Anatomic Sites.Specify tumor site:
Map:HCTv1.0=CDE 2969634:Involvement and Extent of Disease.Specify other metastasis lymph nodes:
Map:HCTv1.0=CDE 2962064:Anatomic Sites.What was the primary CNS tumor site ?
Map:HCTv1.0=CDE 2787385:Anatomic Sites.Specify the biopsy site used to indicate the diagnostic evidence:
Map:HCTv1.0=CDE 2970480:Lab Results.Specify other tissue:
Map:HCTv1.0=CDE 2974004:Disease Response.Specify other site:_
Map:HCTv1.0=CDE 2969616:Lab Results.What biopsy site was positive for neuroblastoma?
Map:HCTv1.0=CDE 3124480:Anatomic Sites.Which sites of neuroblastoma were involved?
Map:HCTv1.0=CDE 2003987:Anatomic Sites.Body Site
Map:HCTv1.0=CDE 2793731:Anatomic Sites.Specify the other site of the organ involvement:
Map:HCTv1.0=CDE 3082348:Involvement and Extent of Disease.What was the site of extranodal involvement?
Map:HCTv1.0=CDE 2970368:Lab Results.Specify the tissue analyzed:
Map:HCTv1.0=CDE 2934832:Anatomic Sites.Select the infection organism site:
Map:HCTv1.0=CDE 2760031:Diagnosis.What is the hemorrhage site?
Map:HCTv1.0=CDE 2871915:Disease, Disorder or Finding.First infectious disorder site:
Map:HCTv1.0=CDE 2952465:Anatomic Sites.Extranodal involvement anatomic site specify:
Map:HCTv1.0=CDE 2793699:Anatomic Sites.Specify the site of the organ involvement:
Map:HCTv1.0=CDE 3061535:Diagnosis.Specify the site of metastasis:
Map:HCTv1.0=CDE 2787340:Anatomic Sites.What is the biopsy site used to indicate the diagnostic evidence:
Map:HCTv1.0=CDE 3009313:Anatomic Sites.Specify other organ system assessed for status:
Map:HCTv1.0=CDE 3086004:Anatomic Sites.Specify the site(s) of primary tumors(s):
Map:HCTv1.0=CDE 61294//:Anatomic Sites.Other specify
Map:HCTv1.0=CDE 2970680:Anatomic Sites.What was the site of disease involvement?
Map:HCTv1.0=CDE 2967298:Diagnosis.What was the site of metastasis?
Map:HCTv1.0=CDE 2987074:Anatomic Sites.Specify other site extra-gonadal metastases present:
Map:HCTv1.0=CDE 2873907:Disease, Disorder or Finding.Second infectious disorder site:
Map:HCTv1.0=CDE 2969632:Anatomic Sites.Which sites did the metastasis lymph nodes present?
Map:HCTv1.0=CDE 2761018:Disease, Disorder or Finding.Speficy the location of active leukemia in the patient:
Map:HCTv1.0=CDE 2760036:Diagnosis.Indicate the site the hemorrhage occurred:
Map:HCTv1.0=CDE 2767//P:Anatomic Sites.Is the primary site or tumor bed involved
Map:HCTv1.0=CDE 2873912:Disease, Disorder or Finding.Third infectious disorder site:
Map:HCTv1.0=CDE 2962066:Anatomic Sites.Specify other primary CNS tumor site:
Map:HCTv1.0=CDE 2969604:Anatomic Sites.What was the location of the breast cancer?
Map:HCTv1.0=CDE 2969639:Lab Results.What was the other biopsy site positive for neuroblastoma?
Map:LSDAMv2.2.3Plus=PerformedObservationResult.targetAnatomicSiteCode
Map:LSDAMv2.2.3Plus=PerformedPathologicalStaging.metastasisSite
Map:SDTM IGv3.1.1=PE.PELOC
Map:SDTM IGv3.1.1=AE.AELOC
Map:SDTM IGv3.1.1=VS.VSLOC
Map:SDTM IGv3.1.1=EX.EXLOC
Map:SDTM IGv3.1.2=PE.PELOC
Map:SDTM IGv3.1.2=AE.AELOC
Map:SDTM IGv3.1.2=FA.FALOC
Map:SDTM IGv3.1.3=TU.TULOC
Map:SDTM IGv3.1.3=PE.PELOC
Map:SDTM IGv3.1.3=AE.AELOC
Map:SDTM IGv3.1.3=FA.FALOC

Notes:

DEFINITION: A coded value specifying the anatomic location that is the focus of an observation result. EXAMPLE(S): arm for skin rash. brain stem or spinal cord for a lesion OTHER NAME(S): NOTE(S): The target site of the result may be different than the target site of the activity (PerformedObservation) that generated it. For example, a chest x-ray (observation) has the target site of chest while the result might show an infiltration in the left lower lobe of the lung (target site of result), or a dermatological exam may check the skin across the whole body (target site of observation) while the result might identify a rash on the right leg (target site of result). Sources that capture anatomic site and laterality separately should map both to this attribute. For implementation models based on BRIDG where site and laterality are captured separately, you may wish to capture both concepts as a post-coordinated code structure or as multiple code repetitions.

Public CD
lateralityCode

Details:

Alias:
Initial:
Stereotype:
Ordered:
Range:	Range:0 to 1
Transient:	False
Derived:	False
IsID:	False

Map:AIM v4 rv48=ImagingPhysicalEntityCharacteristic.typeCode
Map:CTRv1.0=PerformedObservationResult.targetAnatomicSiteLateralityCode
Map:DICOM=TID 1501 MeasurementGroup > Measurement Group > Finding Site > Laterality
Map:DICOM=TID 1419 ROIMeasurements > Measurement Group > Finding Site > Laterality
Map:DICOM=TID 1419 ROIMeasurements > $Measurement parameter > Finding Site > Laterality
Map:DICOM=TID 300 Measurement > $Measurement parameter > Finding Site > Laterality
Map:LSDAMv2.2.3Plus=PerformedObservationResult.targetAnatomicSiteLateralityCode
Map:SDTM IGv3.1.3=TU.TULAT
Map:SDTM IGv3.1.3=FA.FALOC
Map:SEER 2015=SECTION IV DESCRIPTION OF THIS NEOPLASM - LATERALITY

Notes:

DEFINITION: A coded value specifying the side of the body (or a paired organ) that is a target site for an observation result. EXAMPLE(S): bilateral, left, right OTHER NAME(S): NOTE(S): A PerformedObservationResult.targetAnatomicSiteLateralityCode attribute was deprecated in BRIDG 3.1 but added back as TargetAnatomicSite.lateralityCode in 4.0 since source use cases for separate laterality include SDTM and CTOM. This change ensures that users of the BRIDG model are not bound to a particular kind of vocabulary, such as pre- or post-coordinated vocabularies. Collapsing laterality into the target site code is an implementation option.

Public CD
directionalityCode

Details:

Alias:
Initial:
Stereotype:
Ordered:
Range:	Range:0 to 1
Transient:	False
Derived:	False
IsID:	False

Map:DICOM=TID 1501 MeasurementGroup > Measurement Group > Finding Site > Topographical modifier
Map:DICOM=TID 1419 ROIMeasurements > Measurement Group > Finding Site > Topographical modifier
Map:DICOM=TID 300 Measurement > $Measurement parameter > Finding Site > Topographical modifier
Map:DICOM=TID 1419 ROIMeasurements > $Measurement parameter > Finding Site > Topographical modifier
Map:SDTM IGv3.1.3=TU.TUDIR

Notes:

DEFINITION: A coded value specifying the directional portion of the anatomic site that is a target of the observation result. EXAMPLE(S): upper, interior OTHER NAME(S): NOTE(S): This attribute complements the target anatomic site code and target anatomic site laterality code.

Public CD
portionCode

Details:

Alias:
Initial:
Stereotype:
Ordered:
Range:	Range:0 to 1
Transient:	False
Derived:	False
IsID:	False

Map:DICOM=TID 1419 ROIMeasurements > Measurement Group > Finding Site > Topographical modifier
Map:DICOM=TID 300 Measurement > $Measurement parameter > Finding Site > Topographical modifier
Map:DICOM=TID 1501 MeasurementGroup > Measurement Group > Finding Site > Topographical modifier
Map:DICOM=TID 1419 ROIMeasurements > $Measurement parameter > Finding Site > Topographical modifier
Map:SDTM IGv3.1.3=TU.TUPORTOT

Notes:

DEFINITION: A coded value specifying the arrangement or apportionment of the body (or a paired organ) that is a target site for an observation result. EXAMPLE(S): entire, single, segment, many OTHER NAME(S): NOTE(S):

Public BL
primaryIndicator

Details:

Alias:
Initial:
Stereotype:
Ordered:
Range:	Range:0 to 1
Transient:	False
Derived:	False
IsID:	False

Map:HCTv1.0=CDE :2962064:Anatomic Sites.What was the primary CNS tumor site ?

Notes:

DEFINITION: Specifies whether this is the main or principal site. EXAMPLE(S): OTHER NAME(S): NOTE(S):

Element	Source Role	Target Role
PerformedObservationResult Class	Name: describingTargetAnatomicSite	Name: describedPerformedObservationResult
Details: DESCRIPTION:<br/>Each TargetAnatomicSite always describes one PerformedObservationResult. Each PerformedObservationResult might be described by one or more TargetAnatomicSite.<br/><br/>DEFINITION:<br/>Indicates result being described by a particular site.<br/><br/>EXAMPLE(S):<br/><br/>OTHER NAME(S):<br/><br/>NOTE(S):<br/>

Tag	Value
Map:AIM v4 rv48	ImagingPhysicalEntity
Details: